Nitrogen-containing aromatic derivatives

Details Nitrogen-containing aromatic derivatives Nitrogen-containing aromatic derivatives

2007-08-07

2007-08-07

Seaman, D. Margaret (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S155000, C514S312000

Reexamination Certificate

active

10420466

ABSTRACT:
Compounds represented by the following general formula:[wherein Agis an optionally substituted 5- to 14-membered heterocyclic group, etc.; Xgis —O—, —S—, etc.; Ygis an optionally substituted C6-14aryl group, an optionally substituted 5- to 14-membered heterocyclic group, etc.; and Tg1is a group represented by the following general formula:(wherein Egis a single bond or —N(Rg2)—, Rg1and Rg2each independently represent a hydrogen atom, an optionally substituted C1-6alkyl group, etc. and Zgrepresents a C1-8alkyl group, a C3-8alicyclic hydrocarbon group, a C6-14aryl group, etc.)],salts thereof or hydrates of the foregoing.

REFERENCES:
patent: 4764454 (1988-08-01), Ichijima et al.
patent: 5624937 (1997-04-01), Reel et al.
patent: 6143764 (2000-11-01), Kubo et al.
patent: 6534535 (2003-03-01), Zhu et al.
patent: 6797823 (2004-09-01), Kubo et al.
patent: 6821987 (2004-11-01), Kubo et al.
patent: 2004/0253205 (2004-12-01), Yamamoto et al.
patent: 2005/0187236 (2005-08-01), Tsuruoka et al.
patent: 2006/0004029 (2006-01-01), Tsuruoka et al.
patent: 2007/0000477 (2007-01-01), Sakaguchi et al.
patent: 2007/0037849 (2007-02-01), Naito et al.
patent: 0405425 (1990-06-01), None
patent: 0602851 (1994-06-01), None
patent: 0684820 (1995-06-01), None
patent: 0795556 (1997-09-01), None
patent: 0837063 (1997-10-01), None
patent: 0 870 842 (1998-10-01), None
patent: 1029853 (2000-08-01), None
patent: 1 153 920 (2001-11-01), None
patent: 22538448 (1992-09-01), None
patent: 04-341454 (1994-06-01), None
patent: 07-176103 (1997-01-01), None
patent: 08-045927 (1997-09-01), None
patent: 11-158149 (1999-06-01), None
patent: 11-143429 (2000-11-01), None
patent: WO 92/20642 (1992-11-01), None
patent: WO 95/15758 (1995-06-01), None
patent: WO 95/19774 (1995-07-01), None
patent: WO 96/09294 (1996-03-01), None
patent: WO 96/39145 (1996-12-01), None
patent: WO 96/40142 (1996-12-01), None
patent: WO 1997-03069 (1997-01-01), None
patent: WO 97/13760 (1997-04-01), None
patent: WO 97/13771 (1997-04-01), None
patent: WO 97/17329 (1997-05-01), None
patent: WO 97/21437 (1997-06-01), None
patent: WO 97/38984 (1997-10-01), None
patent: WO 98/02434 (1998-01-01), None
patent: WO 98/02437 (1998-01-01), None
patent: WO 98/02438 (1998-01-01), None
patent: WO 98/13350 (1998-04-01), None
patent: WO 98/23613 (1998-06-01), None
patent: WO 98/32436 (1998-07-01), None
patent: WO 98/37079 (1998-08-01), None
patent: WO 98/50346 (1998-11-01), None
patent: WO 98/52558 (1998-11-01), None
patent: WO 99/00357 (1999-01-01), None
patent: WO 99/32106 (1999-07-01), None
patent: WO 99/32110 (1999-07-01), None
patent: WO 99/32111 (1999-07-01), None
patent: WO 99/32436 (1999-07-01), None
patent: WO 99/35132 (1999-07-01), None
patent: WO 99/43654 (1999-09-01), None
patent: WO 00/43366 (2000-07-01), None
patent: WO 00/43384 (2000-07-01), None
patent: WO 2000-42012 (2000-07-01), None
patent: WO 00/44728 (2000-08-01), None
patent: WO 00/47212 (2000-08-01), None
patent: WO 00/50405 (2000-08-01), None
patent: WO 01/36403 (2001-05-01), None
patent: WO 01/45689 (2001-06-01), None
patent: WO 01/47890 (2001-07-01), None
patent: WO 01/47931 (2001-07-01), None
patent: WO06030826 (2006-03-01), None
Bellone, et al., “Growth Stimulation of Colorectal Carcinoma Cells via the c-kit Receptor is Inhibited by TGF-β-1”,Journal of Cellular Physiology, 172: 1-11, 1997.
Berdel, et al., “Recombinant Human Stem Cell Factor Stimulates Growth of a Human Glioblastoma Cell Line Expressing c-kit Protooncogene”,Cancer Research, 52: 3498-3502, 1992.
Bussolino, et al., “Role of Soluble Mediators in Angiogenesis”Eur. J. Cancer, 32A(14): 2401-2412, 1996.
Cohen, et al., “Expression of Stem Cell Factor and c-kit in Human Neuroblastoma”,Blood, 84(10): 3465-3472, 1994.
Deplanque, et al., “Anti-Angiogenic Agents: Clinical Trial Design and Therapies in Development”,European Journal of Cancer, 36: 1713-1724, 2000.
Folkman, J., “New Perspective in Clinical Oncology From Angiogenesis Research”,Eur J. Cancer. 32A(14):2534-2539, 1996.
Folkman, et al., “Angiogenesis”,The Journal of Biological Chemistry, 267(16): 10931-10934, 1992.
Folkman, et al., “clinical Applications of Research on Angiogenesis”,The New England Journal of Medicine, 333(26): 1757-1763, 1995.
Folkman, J., “What is the Evidence that Tumors are Angiogenesis Dependent?”,Journal of the National Cancer Institute, 82(1): 4-6, 1990.
Furitsu, et al., “Identification of Mutations in the Coding Sequence of the Proto-Oncogene c-kit in a Human Mast Cell Leukemia Cell Line Causing Ligand-Independent Activation of c-kit Product”J. Clin. Invest. 92: 1736-1744, 1993.
Furuta, et al., “Synthesis and Biological Evaluation of Selective Inhibitors of PDGF Receptor Auto Phosphorylation”Pharmaceutical Research Laboratories, Kirin Brewery Co., Ltd., Takasaki, Gunma, Japan.
Golkar, et al., “Mastocytosis”,Lancet, 349: 1379-1385, 1997.
Hamel, et al., The Road Less Travelled: c-kit and Stem Cell Factor,Journal of Neuro-Oncology, 35:327-333, 1997.
Hibi, et al., “Coexpression of the Stem Cell Factor and the c-kit Genes in Small-Cell Lung Cancer”,Oncogene, 6: 2291-2296, 1991.
Hines, et al., “Coexpression of the c-kit and Stem Cell Factor Genes in Breast Carcinomas”,Cell Growth&Differentiation, 6: 769-779, 1995.
Hogaboam, et al., “Novel Role of Transmembrane SCF for Mast Cell Activation and Eotaxin Production in Mast Cell-Fibroblast Interactions”,The Journal of Immunology, 160: 6166-6171, 1998.
Ikeda, et al., “Changes in Phenotype and Proliferative Potential of Human Acute Myeloblastic Leukemia Cells in Culture with Stem Cell Factor”,Experimental Hematology, 21: 1686-1694, 1993.
Ikeda, et al., “Expression and Functional Role of the Proto-Oncogene c-kit in Acute Myeloblastic Leukemia Cells”,Blood, 78(11): 2962-2968, 1991.
Blume-Jensen, et al., “Activation of the Human c-kit Product by Ligand-Induced Dimerization Mediates Circular Actin Reorganization and Chemotaxis”,The EMBO Journal, 10(13): 4121-4128, 1991.
Kanakura, et al., “Expression, Function and Activation of the Proto-Oncogene c-kit Product in Human Leukemia Cells”,Leukemia and Lymphoma, 10: 35-41, 1993.
Kay, et al., “Eosinophils and Eosinophil-Associated Cytokines in Allergic Inflammation”,Int. Arch. Allergy Immunol. 113: 196-199, 1997.
Kitamura, et al., “Regulation of Development, Survival and Neoplastic Growth of Mast Cells through the c-kit Receptor”,Int Arch Allergy Immunol., 107: 54-56, 1995.
Kolibaba, et al., “Protein Tyrosine Kinases and Cancer”,Biochimica et Biophysica Acta, 1333: F217-F248, 1997.
Kotva, et al., “Substances with Antineoplastic Activity, LIII. N-(δ-(4-Pyrrolo[2,3-d]Pyrimidinylthio) Valeryl} Amino Acids and Analogous Derivatives of Di-and Triglycine”,Collection Czechoslov. Chem. Commun. 38: 1438-1444, 1973.
Lasota, et al., “Mutations in Exons 9 and 13 of KIT Gene Are Rare Events in Gastrointestinal Stromal Tumors”,American Journal of Pathology, 157(4): 1091-1095, 2000.
Lev, et al., “A Specific Combination of Substrates is Involved in Signal Transduction by the Kit-Encoded Receptor”,The EMBO Journal, 10(3): 647-654, 1991.
Longley, et al., “Altered Metabolism of Mast-Cell Growth Factor (c-kit Ligand) in Cutaneous Mastocytosis”,The New England Journal of Medicine, 328(18): 1302-1307, 1993.
Longley, et al., “Somatic c-KIT Activating Mutation in Urticaria Pigmentosa and Aggressive Mastocytosis: Establishment of Clonality in a Human Mast Cell Neoplasm”,Nature Genetics, 12: 312-314, 1996.
Lukacs, et al., “Stem Cell Factor (c-kit Ligand) Influences Eosinophil Recruitment and Histamine Levels in Allergic Airway Inflammation”,The Journal of Immunology, 156: 3945-3951, 1996.
Meltzer, E.O., “The Pharmacological Basis for the Treatment of

Affiliated with

Also associated with

Rating

Nitrogen-containing aromatic derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nitrogen-containing aromatic derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitrogen-containing aromatic derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3860607